| For: | Yu XH, Xie Y, Yu J, Zhang KN, Guo ZB, Wang D, Li ZX, Zhang WQ, Tan YY, Zhang L, Jiang WT. Loss-of-function mutations of microRNA-142-3p promote ASH1L expression to induce immune evasion and hepatocellular carcinoma progression. World J Gastroenterol 2025; 31(1): 101198 [PMID: 39777247 DOI: 10.3748/wjg.v31.i1.101198] | 
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i1/101198.htm | 
| Number | Citing Articles | 
| 1 | 
                             
                                            Chenlie Ni, Qiwen Sun, Haibo Yin. Comprehensive multi-omics analysis of histone acetylation modulators identifies ASH1L as a novel aggressive marker for osteosarcoma. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02920-6
                                         
                                     | 
                    
| 2 | 
                             
                                            Mozhgan Sheikholeslami, Saeideh Jafarinejad-Farsangi, Hamidreza Soleimanpour Lichaei, Dor Mohammad Kordi Tamanadani. miR-142-3p as a Candidate Biomarker for Early-Stage Lung Adenocarcinoma: Integrative Bioinformatics Analysis and experimental Validation. Biomarkers 2025; : 1 doi: 10.1080/1354750X.2025.2578000
                                         
                                     | 
                    
